Beijing Strong Biotechnologies Inc (300406) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Beijing Strong Biotechnologies Inc (300406) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥182.86 Million ≈ $26.76 Million USD) by net assets (CN¥4.00 Billion ≈ $584.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Beijing Strong Biotechnologies Inc - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Beijing Strong Biotechnologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Beijing Strong Biotechnologies Inc for a breakdown of total debt and financial obligations.

Beijing Strong Biotechnologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Strong Biotechnologies Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Suzhou Hycan Holdings Co Ltd SHE:002787	0.088x
Nusantara Sawit Sejahtera JK:NSSS	0.079x
Wuzhou Special Paper Group Co. Ltd. SHG:605007	0.070x
Waypoint REIT AU:WPR	0.029x
Xinjiang Baodi Mining Co. Ltd. A SHG:601121	N/A
WAVE LIFE SCIENCES LTD. F:1U5	-0.065x
VIEL & Cie société anonyme PA:VIL	0.111x
Instalco Intressenter AB ST:INSTAL	0.133x

Annual Cash Flow Conversion Efficiency for Beijing Strong Biotechnologies Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Strong Biotechnologies Inc from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 300406 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.13 Billion ≈ $604.76 Million	CN¥614.01 Million ≈ $89.85 Million	0.149x	-6.31%
2023-12-31	CN¥3.72 Billion ≈ $544.58 Million	CN¥590.15 Million ≈ $86.36 Million	0.159x	+30.84%
2022-12-31	CN¥3.27 Billion ≈ $478.32 Million	CN¥396.17 Million ≈ $57.97 Million	0.121x	+3.52%
2021-12-31	CN¥2.91 Billion ≈ $426.32 Million	CN¥341.10 Million ≈ $49.91 Million	0.117x	+225.72%
2020-12-31	CN¥3.42 Billion ≈ $500.96 Million	CN¥123.06 Million ≈ $18.01 Million	0.036x	-62.44%
2019-12-31	CN¥1.97 Billion ≈ $288.41 Million	CN¥188.60 Million ≈ $27.60 Million	0.096x	-36.41%
2018-12-31	CN¥1.70 Billion ≈ $249.09 Million	CN¥256.15 Million ≈ $37.48 Million	0.150x	+10.74%
2017-12-31	CN¥1.53 Billion ≈ $223.89 Million	CN¥207.91 Million ≈ $30.42 Million	0.136x	-22.45%
2016-12-31	CN¥1.39 Billion ≈ $203.11 Million	CN¥243.21 Million ≈ $35.59 Million	0.175x	+44.42%
2015-12-31	CN¥1.18 Billion ≈ $171.97 Million	CN¥142.59 Million ≈ $20.86 Million	0.121x	-23.69%
2014-12-31	CN¥987.03 Million ≈ $144.43 Million	CN¥156.94 Million ≈ $22.97 Million	0.159x	-48.55%
2013-12-31	CN¥476.31 Million ≈ $69.70 Million	CN¥147.19 Million ≈ $21.54 Million	0.309x	-5.02%
2012-12-31	CN¥385.67 Million ≈ $56.44 Million	CN¥125.49 Million ≈ $18.36 Million	0.325x	+104.63%
2011-12-31	CN¥288.66 Million ≈ $42.24 Million	CN¥45.90 Million ≈ $6.72 Million	0.159x	--

About Beijing Strong Biotechnologies Inc

SHE:300406 China Diagnostics & Research

Market Cap

$1.12 Billion

CN¥7.67 Billion CNY

Market Cap Rank

#8707 Global

#2322 in China

Share Price

CN¥13.08

Change (1 day)

+1.40%

52-Week Range

CN¥11.43 - CN¥15.30

All Time High

CN¥24.76